VOR
Vor BiopharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
VOR Profile
Vor Biopharma Inc.
A clinical stage cell therapy company to develop therapies for hematological malignancies patients
P.O. Box 380121, Cambridge, Massachusetts 02238
--
Vor Biopharma Inc., a wholly-owned subsidiary of PureTech Health LLC, was incorporated in Delaware on December 30, 2015. The company is a clinical-stage cell therapy company that combines novel patient engineering approaches and targeted therapies to provide a single company solution for patients with hematological malignancies. The company's proprietary platform leverages its expertise in hematopoietic stem cell biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. Vor is headquartered in Cambridge, Massachusetts.
